ImmunoPrecise Antibodies

Home
ImmunoPrecise Antibodies

All-in-one biointelligence ecosystem unifying AI, data, and advanced lab research to drive new breakthroughs in biologics discovery
www.mindwalkai.com

MindWalk formerly known as IPA (ImmunoPrecise Antibodies). MindWalk is redefining biologics discovery and development by uniting bio-native AI, multi-omics data integration, and advanced lab research into a single customizable ecosystem. With cutting-edge technology and validated scientific outputs, we deliver up to 3X faster insights—guiding workflows in new directions, giving researchers deeper

data-driven understanding of sequence, structure, and function, expanding antibody diversity, and refining candidates earlier to reduce time and costs, turning complexity into breakthroughs. Together, let’s push the boundaries and shape the future of human health.

10/04/2023

We are super excited about LENSᵃⁱ™, game-changing software transforming the world of genomics!

Developed by BioStrand (an IPA company), LENSᵃⁱ uses proprietary and patented HYFT technology with a multi-lingual language model to unlock the secrets of complex biological data, much like ChatGPT processes human language! It's paving the way for breakthroughs in medicine, biotechnology, and personalized healthcare.

It's thrilling to see IPA pushing the boundaries of innovation and making a real impact on the future of healthcare. Check out IPA on NASDAQ and support the visionaries who are shaping a healthier tomorrow for all of us!

12/07/2022

As news of COVID-19 and its emerging subvariants surge, IPA proudly announces IND preclinical safety data for PolyTope TATX-03 antibody cocktail and its potential to prevent and treat COVID-19. This data from IPA illustrates the company's reputation for uncompromising scientific standards and dedication to sustainable biotherapeutic solutions. https://bit.ly/3RuLaAE

27/06/2022

We honor PRIDE month and its commemoration of the values we share to nurture a colorful, diverse and inclusive culture at IPA – and across the world.

23/06/2022

IPA is looking forward to embarking on the exciting opportunities and new partnerships that took shape last week at BIO International. We are more excited than ever to introduce a whole new approach to making personalized medicine a reality! www.immunoprecise.com/ipa

15/06/2022

Learn how we proudly build on our reputation of scientific excellence with a new approach to personalized medicine. BIO - IPA booth 4017 or go to: https://bit.ly/3tDvOQ1

07/06/2022

Access the Talem vault of next-gen, fully human programs OR co-pilot a mission to explore untapped targets with your data — from a whole new LENSai. For more options to personalize therapeutics with meaningful specificity for oncology and beyond, go to: https://bit.ly/3Gqstsu to schedule a meeting at BIO International 2022, or for more information

06/06/2022

Join IPA at AET Europe to learn more about our HUB of Biotherapeutic Intelligence, including our new LENSai Complex Intelligence Technology. https://bit.ly/3Q37iRI

25/05/2022

Access the Talem vault of next-gen, fully human programs OR co-pilot a mission to explore untapped targets with your data — and a whole new LENSai. For more options to personalize therapeutics with meaningful specificity for oncology and beyond, go to: https://bit.ly/3NBvqJf to schedule a meeting at BIO International 2022, or for more information

Address

823 Congress Avenue

78701

Telephone

+18006204187

Website

https://www.mindwalkai.com/

Alerts

Be the first to know and let us send you an email when ImmunoPrecise Antibodies posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your business to be the top-listed Engineering Company?

Country:

City:

Our Story

With over two decades of experience, ImmunoPrecise Antibodies is a global leader in custom antibody development, using innovative technologies such as B Cell Select™️ and DeepDisplay™️, to ensure broad antibody diversity and unique species capabilities.